Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 15,251.85% | 13.78% | -24.36% | -- | 100.18% |
| Total Depreciation and Amortization | -11.21% | -27.61% | -21.48% | -- | 8.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.01% | -34.86% | -156.93% | -- | -240.91% |
| Change in Net Operating Assets | 141.47% | 146.66% | -120.30% | -- | -12.42% |
| Cash from Operations | 52.86% | 37.91% | -394.95% | -- | -31.75% |
| Capital Expenditure | -2.85% | 38.55% | 63.35% | -- | 45.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.79% | 18.30% | 10.27% | -- | 49.69% |
| Cash from Investing | 1,267.51% | 77.84% | 61.71% | -- | 45.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | 2,576.90% | -- | -- | -51.44% |
| Repurchase of Common Stock | -300.00% | 78.95% | 72.00% | -- | 95.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.14% | 2,850.41% | 72.00% | -- | -62.52% |
| Foreign Exchange rate Adjustments | -316.74% | -182.82% | -68.19% | -- | -44.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.81% | 114.35% | -1,627.87% | -- | -133.38% |